2 Result: Exelixis
Biotech Earnings Ahead for Exelixis, Gilead Sciences, Incyte
February 08th, 2026
Las Vegas, NV / CRWE PRESS RELEASE / February 8, 2026 - Among the companies expected to release their financial results on Tuesday, February 10, are: Exelixis, Inc. (Nasdaq: EXEL), a biotechnology company focused on oncology therapies, will releas. Read more
Earnings Snapshot: A Preview of CyberArk, Exelixis, and Gevo
May 10th, 2025
Several companies are preparing to report their quarterly earnings on Tuesday, May 13, including: CyberArk Software Ltd. (Nasdaq: CYBR), a cybersecurity firm specializing in identity security and privileged access management, will release its firs. Read more
Load More Content
Member Login